Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea

Eye Contact Lens. 2006 Jul;32(4):161-5. doi: 10.1097/01.icl.0000185041.08549.45.

Abstract

Purpose: To evaluate the toxicity of fourth-generation fluoroquinolone antibiotic solutions on the rabbit corneal epithelium.

Methods: In vivo confocal microscopy was used to assess epithelial structure in 18 rabbits, and tight junction integrity of superficial epithelial cells was evaluated with ZO-1 labeling in 10 rabbits. Eyes were bathed with commercial solutions of moxifloxacin (Vigamox) or gatifloxacin (Zymar) solution for 3 minutes, rinsed with balanced salt solution, and immediately examined. Balanced salt solution rinsing alone served as the control.

Results: A decrease in epithelial cell size was observed after treatment with Zymar (P < 0.05, two-way repeated-measures analysis of variance), but not with Vigamox or the control. Normal ZO-1 organization was observed in controls and eyes treated with Vigamox. ZO-1 staining in eyes treated with Zymar was disrupted, patchy, and generally weaker than that in control eyes.

Conclusions: After short-term, intensive exposure to Vigamox, corneal epithelial integrity and tight junction organization are maintained. Zymar induces a loss of superficial epithelial cells and breakdown of tight junctions under similar conditions.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aza Compounds / administration & dosage
  • Aza Compounds / toxicity*
  • Epithelium, Corneal / drug effects*
  • Epithelium, Corneal / metabolism
  • Epithelium, Corneal / pathology*
  • Fluoroquinolones / administration & dosage
  • Fluoroquinolones / toxicity*
  • Gatifloxacin
  • Immunohistochemistry
  • Membrane Proteins / metabolism
  • Microscopy, Confocal
  • Moxifloxacin
  • Ophthalmic Solutions
  • Phosphoproteins / metabolism
  • Quinolines / administration & dosage
  • Quinolines / toxicity*
  • Rabbits
  • Zonula Occludens-1 Protein

Substances

  • Aza Compounds
  • Fluoroquinolones
  • Membrane Proteins
  • Ophthalmic Solutions
  • Phosphoproteins
  • Quinolines
  • Zonula Occludens-1 Protein
  • Gatifloxacin
  • Moxifloxacin